Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Enteral Nutrition × Clear all

Phase

Status

Sponsor Class

OTHER 22 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Cerebral Palsy 1

Interventions

pembrolizumab 885 Carboplatin 834 Paclitaxel 823 Gemcitabine 682 Cisplatin 662 Docetaxel 622 Bevacizumab 557 Nivolumab 439 Pemetrexed 428 Cyclophosphamide 416 Capecitabine 406 Fluorouracil 353 Dexamethasone 346 Rituximab 344 Oxaliplatin 300 Injections 291 atezolizumab 273 Trastuzumab 270 Cetuximab 248 Leucovorin 244 Irinotecan 229 Prednisone 228 130-nm albumin-bound paclitaxel 222 Doxorubicin 216 Ipilimumab 202 Lenalidomide 200 Fulvestrant 193 fludarabine 186 durvalumab 182 Drug Therapy 179

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07341464 2026-01-14

Blends

Société des Produits Nestlé (SPN)

Phase NA Recruiting

Cerebral Palsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡